Use of CAR T-cell Therapy in Earlier Lines in Relapsed Refractory Multiple Myeloma

Opinion
Video

Panelists discuss how the use of CAR T-cell therapy in earlier lines of treatment for relapsed/refractory multiple myeloma could potentially improve long-term outcomes, considering factors such as patient selection, optimal timing, and the impact on subsequent treatment options.

Recent Videos
Vinay K. Puduvalli, MD, is featured in this series.
9 Experts are featured in this series.
2 experts are featured in this series.
Vinay K. Puduvalli, MD, is featured in this series.
2 experts are featured in this video
2 experts are featured in this video
2 experts are featured in this video
4 KOLs are featured in this series.
9 Experts are featured in this series.
9 Experts are featured in this series.